Prices delayed by at least 15 minutes | Print


Ginkgo Bioworks Holdings (DNA)

Ordinary Shares
Sell: $0.9|Buy: $0.907|Change: 0.10 (-9.97%)

Open 

$0.98


Previous close 

$0.9898


Trade high 

$1.01


Volume 

66,093,955


Year high 

$2.55


Year low 

$0.74


Dividend yield 

-


Market capitalisation 

$1.92 bn


P/E ratio 

-


ISIN 

US37611X1000


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Performance 29/04/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Ginkgo Bioworks Holdings+ 15.08
More...

Company profile

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.